Biome Australia Ltd · ASX:BIO
Biome Australia — Investor Presentation (November 2024)
22 slides from Biome Australia's investor presentation, Nov 18, 2024
Slide 1: Company Presentation November 2024
Biome Australia For personal use only November 2024 Company Jan 2024 Strategy Meeting Presentation Blair Vega Norfolk, Founder & Managing Director Company Presentation | November 2024 1
Slide 2: Disclaimer
Biome Australia Disclaimer For personal use only This presentation and the information contained within it (the This presentation contains forward-looking statements, which may be The recipient must, and agrees with the Company that it will, make its “information”) has been prepared solely for the u
Slide 3: About Biome Australia
Biome Australia For personal use only About Biome Australia Biome Australia (ASX: BIO) is focused on becoming a global leader in the complementary medicine industry, offering clinically-proven, condition-specific probiotic products fueled by novel clinical research programs to cement and extend the
Slide 4: Our mission
Biome Australia Group The Microbiome Health Company For personal use only Our mission To prevent disease, improve health outcomes and quality of life, and make our products accessible to all Company Presentation | November 2024 4
Slide 5: Company Vision Presentation
Biome Australia Group The Microbiome Health Company For personal use only Company Vision Presentation 27 Strategic Plan | November 2024 55
Slide 6: Activated Probiotics Range
Biome Australia For personal use only 02. Activated Probiotics Range Company Presentation | November 2024 2024 6
Slide 7: Activated Probiotics
Biome Australia Activated For personal use only Probiotics Practitioners & Pharmacies CONSUMER BENEFITS 5x more effective delivery — MicrobacTM technology Shelf-stable Clinically documented probiotic strains Company Presentation | November 2024 7
Slide 8: Business Highlights
Biome Australia For personal use only 01. Business Highlights Company Presentation | November 2024 8
Slide 9: Business Highlights
Biome Australia For personal use only Biome Business Over 5,000 distribution points (Aus) following successful launch with Priceline Pharmacy Highlights Average shopper ~2 units per transaction and 6 visits per year in pharmacy (Terry White Scan data) #1 growth Practitioner-Only brand in Australian
Slide 10: Distribution and Sales Model
Biome Australia For personal use only 03. Distribution and Sales Model Company Presentation | November 2024 10
Slide 11: Training and Education Driven Sales Model - Practitioner Only
Biome Australia Training and Education Driven For personal use only Sales Model - Practitioner Only Unique Education and Service Model Drives Sales in Australia, UK and NZ Education and Service Support • The Biome sales team is a mix of health qualified practitioner education consultants and territo
Slide 12: Vision
Biome Australia For personal use only 04. Vision 27 Company Presentation | November 2024 12
Slide 13: Vision: Revenue Growth
Biome Australia Vision 27 For personal use only Revenue Growth Biome has a three year cumulative sales revenue target of up to $85m. ($75m-$85m for FY25-FY27) 1. Distribution Growth & Business Development ● Grow the existing 5000 (~40% TAM for distribution) Australian distribution points (Pharmacy a
Slide 14: Vision: Supply Chain and New Brand and Product Range
Biome Australia For personal use only Vision 27 3. Supply Chain Bring Activated Probiotics to the mainstream market as a ● Identification and viability analysis of a novel probiotic strain that is significant probiotic brand locally and abroad. proprietary to Biome ○ Lactobacillus plantarum BMB18 ○ Su
Slide 15: IP Development
Biome Australia For personal use only 03. IP Development Company Presentation | November 2024 15
Slide 16: BMB18
Biome Australia For personal use only BMB18 Biome has executed an agreement to develop a Biome owned novel probiotic strain ● Lactobacillus plantarum BMB18 Biome has successfully completed the identification, commercial validation and initial characterisation of the probiotic strain Lactobacillus pla
Slide 17: International Markets
Biome Australia For personal use only 05. International Markets Company Presentation | November 2024 2024 17
Slide 18: Canada — North America
Biome Australia For personal use only Canada — North America International markets grow 95% to reach ~$895k in sales revenue for FY24 ● Health Canada Approvals received in H2 FY24 (12/17 Activated Probiotics products) ● Test market launch successful with Ecotrend In Q1 FY25 ● First territory manager
Slide 19: New Product Development
Biome Australia For personal use only 06. New Product Development Company Presentation | November 2024 19
Slide 20: For personal use only
Biome Australia Group The Microbiome Health Company For personal use only Company Presentation | November 2024 20 20
Slide 21: Summary
Biome Australia For personal use only Summary ● FY24 Sales Revenue $13.01m, up 80% ● FY25 Q1 pharmacy same stores sales up 68% (vs PCP) ● Q1 FY25 Sales Revenue $4.25m (new record) ● Three ongoing clinical trials on key products ● Q1 $122,000 EBITDA adjusted for non-cash, share-based payments) ● Aver
Slide 22: Contact details
Biome Australia For personal use only Contact details Blair Norfolk, CEO Douglas Loh, CFO Email corporate@biomeaustralia.com Websites biomeaustralia.com activatedprobiotics.com.au Company Presentation | November 2024 22
Biome Australia — Investor Presentation (November 2024) on 6ix